The tumor-suppressive effect of K-Ras overexpression was also shown in 4 other pancreatic cancer cell lines, including Pa03C, ASPC1, PANC10.05, and PANC198, as well as MDA-MB-231 breast cancer cells (Fig. 1F; Supplementary Fig. 2). Here, KRAS is linked to pancreatic neoplasm.